Literature DB >> 8620088

Eosinophils in allergy: role in disease, degranulation, and cytokines.

L B Martin1, H Kita, K M Leiferman, G J Gleich.   

Abstract

For over 100 years, the eosinophil has been associated with allergic disease. At present, eosinophils appear to be associated pathologically with asthma, atopic dermatitis, allergic rhinitis, eosinophilic gastroenteritis, and certain eye diseases. The effector functions of eosinophils appear to be derived primarily from release of lipid mediators and proteins, including cytokines and granule proteins. Eosinophil degranulation results in the release of several cytotoxic cationic granule proteins. Furthermore, release of cytokines by eosinophils and other cells involved in inflammation amplifies and regulates localized immune responses. Altogether, the eosinophil's capacity to release and be influenced by a variety of mediators, including the granule proteins and cytokines, implicates this cell in the pathology of inflammation and in the perpetuation of the inflammatory response.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8620088     DOI: 10.1159/000237239

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  33 in total

1.  A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.

Authors:  N Cooper; M M Teixeira; J Warneck; J M Miotla; R E Wills; D M Macari; R W Gristwood; P G Hellewell
Journal:  Br J Pharmacol       Date:  1999-04       Impact factor: 8.739

Review 2.  Allergic rhinitis/asthma interrelationships.

Authors:  T B Casale; B V Amin
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

3.  DNase I footprinting of the human interleukin-5 gene promoter.

Authors:  D J Cousins; D Richards; D M Kemeny; S Romagnani; T H Lee; D Z Staynov
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

4.  Functional characterization and biomarker identification in the Brown Norway model of allergic airway inflammation.

Authors:  Stephen L Underwood; El-Bdaoui Haddad; Mark A Birrell; Kerryn McCluskie; Michaela Pecoraro; Dominika Dabrowski; Stephen E Webber; Martyn L Foster; Maria G Belvisi
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 5.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

Review 6.  Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders.

Authors:  Steven J Ackerman; Bruce S Bochner
Journal:  Immunol Allergy Clin North Am       Date:  2007-08       Impact factor: 3.479

Review 7.  "Ultimate activation" of eosinophils in vivo: lysis and release of clusters of free eosinophil granules (Cfegs).

Authors:  C G Persson; J S Erjefält
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

8.  alpha(4) integrin-dependent eosinophil recruitment in allergic but not non-allergic inflammation.

Authors:  M M Teixeira; M K Robinson; A Shock; P G Hellewell
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

9.  Aging Dampens the Intestinal Innate Immune Response during Severe Clostridioides difficile Infection and Is Associated with Altered Cytokine Levels and Granulocyte Mobilization.

Authors:  Lisa Abernathy-Close; Michael G Dieterle; Kimberly C Vendrov; Ingrid L Bergin; Krishna Rao; Vincent B Young
Journal:  Infect Immun       Date:  2020-05-20       Impact factor: 3.441

Review 10.  Pathogenesis of nasal polyposis.

Authors:  K E Hulse; W W Stevens; B K Tan; R P Schleimer
Journal:  Clin Exp Allergy       Date:  2015-02       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.